V-Square Quantitative Management
UTHR icon

V-Square Quantitative Management’s United Therapeutics UTHR Stock Holding History

V-Square Quantitative Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$76.4K Hold
141
– – 0.01% 558
2026
Q2 		$76.4K Buy
141
+8
+6% +$4.5K 0.01% 551
2026
Q1 		$78.9K Buy
133
+16
+14% +$7.97K 0.01% 557
2025
Q4 		$57K Buy
+117
New +$54.5K 0.01% 570
2025
Q3 		– Sell
-113
Closed -$32.5K – 571
2025
Q2 		$32.5K Sell
113
-4
-3% -$1.2K ﹤0.01% 559
2025
Q1 		$36.1K Hold
117
– – 0.01% 609
2024
Q4 		$41.3K Buy
117
+4
+4% +$1.47K 0.01% 593
2024
Q3 		$40.5K Buy
113
+19
+20% +$6.42K 0.01% 564
2024
Q2 		$29.9K Buy
+94
New +$24.9K ﹤0.01% 562

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Vilga Financial Planning
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

V-Square Quantitative Management's UTHR Position: Q3 2026 in Review

V-Square Quantitative Management held its United Therapeutics (UTHR) position steady in Q3 2026 at 141 shares worth $76.4K. The position accounts for 0.01% of the portfolio, ranked #558.

V-Square Quantitative Management first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $78.9K in Q1 2026. 131 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • V-Square Quantitative Management held 141 shares of United Therapeutics worth $76.4K as of Q3 2026.
  • V-Square Quantitative Management left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up 0.01% of V-Square Quantitative Management's portfolio in Q3 2026, its #558 holding.
  • V-Square Quantitative Management first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • V-Square Quantitative Management's United Therapeutics position peaked at $78.9K in Q1 2026.
  • 131 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.